Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 923093 STAMFORD, CT

Position in MLYS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$19,921,222
+$15,702,226 QoQ
Shares Held
738,370
+374.1% QoQ
Ownership
0.835%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#37
of 224 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in MLYS Over Time

Shares Held

Position Value (USD)

Derivatives in MLYS

reported options exposure · as of Jun 30, 2026
CallValue
$202,350
CallShares
7,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names. MLYS ranks #6 (4.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 MLYS
Mineralys Therapeutics, Inc.
This page
738,370 $19,921,222

All Filings in MLYS

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,921,222 738,370
2026-06-30 $202,350 7,500
2026-03-31 $17,760,204 655,600
2026-03-31 $6,482,637 239,300
2026-03-31 $4,218,996 155,740
2025-12-31 $19,440,553 535,700
2025-12-31 $21,269,569 586,100
2025-12-31 $1,416,979 39,046